QPS Acquires Bioserve, India

QPS, LLC, a global CRO supporting drug discovery and development announced the acquisition of a majority stake in Bioserve Clinical Research, a full service phase 1 CRO in India.

QPS, LLC has acquired of a majority stake in Bioserve Clinical Research. Bioserve, a full service phase I CRO based in Hyderabad, India, will be known as QPS-Bioserve India. QPS is a worldwide CRO supporting drug discovery and development, with expertise in preclinical DMPK/toxicology, bioanalytical, translational medicine, and early- and late-stage clinical research.

Bioserve has a 92-bed clinical unit for conducting phase I studies and a bioanalytical lab equipped with multiple LC/MS/MS systems for small molecule bioanalysis. In the past six years, it has conducted more than 500 studies, with numerous product approvals, and has been inspected by the USFDA, UK MHRA, WHO and Indian DCGI.

"This new partnership further expands QPS' global range of